Siapa Perempuan Tajir yang Terlibat Skandal dengan Mantan Menkes Inggris ? tribunnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribunnews.com Daily Mail and Mail on Sunday newspapers.
Matt Hancock s wife: The quietly dignified osteopath descended from a baron and a viscount yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Posted on 389
Ixaka Ltd, an integrated cell and gene therapy company focused on the natural power of the body to cure disease, today announces that Christian Hoyer Millar has joined the Company’s Board as a Non-Executive Director.
Christian Hoyer Millar has extensive corporate experience across life sciences and biotech. He is the Founder and a current Director of both Chronos Therapeutics Limited and Sibelius Limited. Previously, up until 2020 Christian was also the Founder, Director and CEO of Oxford Biodynamics, an Oxford University spin out and world leader in 3D genomics, which went public on the AIM market in 2017.
Christian started his career at the Boston Consulting Group, working in both Europe and the US. Christian then moved to the UK holding company of the Dutch conglomerate Hoogovens, where he acted as Director for numerous subsidiaries. He moved on to become Vice President of Fox Pitt Kelton, supporting
About Oxford BioDynamics Plc Oxford BioDynamics Plc (AIM: OBD) is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases. The Company has developed a proprietary 3D genomic biomarker platform, EpiSwitch™, which can build molecular diagnostic classifiers for prediction of response to therapy, patient prognosis, disease diagnosis and subtyping, and residual disease monitoring in a wide range of indications. Oxford BioDynamics has participated in more than 40 partnerships with big pharma and leading institutions including Pfizer, EMD Serono, Genentech, Roche, Biogen, Mayo Clinic, Massachusetts General Hospital and Mitsubishi Tanabe Pharma.
The Company has created a valuable technology portfolio, including biomarker arrays, molecular diagnostic tests, bioinformatic tools for 3D genomics and an expertly curated 3D genome knowledgebase comprising